2021 Covid-19 Vaccines and Clinical Trials Update

2021 Covid-19 Vaccines and Clinical Trials Update

In December we published a report on up and coming Covid-19 Vaccines from around the world. This month we are publishing an update on approved Covid 19 Vaccines and promising Covid-19 Vaccine candidates that have reached phase 3 clinical trials. We have indicated background information, Trial Design, their status for each.

 

 

This report is co-published with the drug regulatory consultancy SPharm and provided to you in a format that is hopefully useful to digest. All vaccine information, clinical trial data, summaries, content and references have been referenced directly from clinicaltrials.gov provided by the National Institutes of Health, by the Regulatory Affairs Professionals Society (RAPS),  the New York Times Coronavirus Vaccine Tracker, by Health Canada and by CNN Health.

 

 

Download the 2021 Covid-19 Vaccines report now

 


TAKE THE NEXT STEP

Have any questions about your clinical trial design, protocol, or data? Ask our experts for their input or guidance. We are happy to help.

Need ballpark pricing, a comprehensive proposal, an RFP/RFI filled, review of your design, data or your development plan?

Download whitepapers, eGuides, infographics, presentations, articles and other relevant content from our resource center.


CONTACT

McDougall Scientific

789 Don Mills Road, Suite 802, Toronto, Ontario M3C 1T5 Canada
Phone: (416) 424-2092

MCDOUGALL SCIENTIFIC

Providing 40 years of quality service, McDougall Scientific is one of the most experienced Clinical Research Organizations around, focused on Clinical Trial Design, Statistical Analysis and Clinical Data Management. We invite you to see how we exceed our clients’ expectations.